首页|奥曲肽治疗乙肝后肝硬化失代偿期顽固性腹水疗效观察

奥曲肽治疗乙肝后肝硬化失代偿期顽固性腹水疗效观察

扫码查看
目的:探讨奥曲肽治疗乙肝后肝硬化失代偿顽固性腹水的疗效。方法:46例患者随机分为2组,对照组给予纠正低蛋白血症、利尿、维持电解质平衡、抗病毒等常规治疗。治疗组在上述基础上加用奥曲肽0.1mg 皮下注射 tid 。结果:治疗组相比对照组尿量增加、腹水减少,体重减轻。治疗组总体有效率为82.61%,明显高于对照组56.52%的治疗有效率。结论:奥曲肽在治疗乙肝后肝硬化顽固性腹水效果显著。
Objective: To investigate octreotide treatment of decompensated liver cirrhosis with refractory ascites effect.Methods: 46 patients were randomly divided into two groups, a control group was given hypoproteinemia, diuretic, to maintain electrolyte balance, anti-virus and other conventional treatment. In the treatment group, based on the use of octreotide 0.1mg subcutaneous tid. Results: The treatment group compared to the control group to increase the amount of urine, ascites, weight loss. The overal effective rate of the treatment group 82.61%, significantly higher than 56.52% of the treatment efficiency.Conclusion:Octreotide in the treatment of liver cirrhosis with refractory ascites effect is remarkable.

Octreotidehepatitis B cirrhosisrefractory ascites

奥曲肽 乙肝后肝硬化 顽固性腹水

2014

中国保健营养(中旬刊)
全国卫生产业企业管理协会

中国保健营养(中旬刊)

ISSN:1004-7484
年,卷(期):2014.(6)
  • 1
  • 3